EML5
gene geneOn this page
Also known as HuEMAP-2EMAP-2FAP16
Summary
EML5 (EMAP like 5, HGNC:18197) is a protein-coding gene on chromosome 14q31.3, encoding Echinoderm microtubule-associated protein-like 5 (Q05BV3). May modify the assembly dynamics of microtubules, such that microtubules are slightly longer, but more dynamic.
Predicted to enable microtubule binding activity. Located in extracellular exosome.
Source: NCBI Gene 161436 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 259 total
- MANE Select transcript:
NM_183387
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18197 |
| Approved symbol | EML5 |
| Name | EMAP like 5 |
| Location | 14q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HuEMAP-2, EMAP-2, FAP16 |
| Ensembl gene | ENSG00000165521 |
| Ensembl biotype | protein_coding |
| OMIM | 618119 |
| Entrez | 161436 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 4 protein_coding, 2 nonsense_mediated_decay, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000380664, ENST00000553281, ENST00000553320, ENST00000553526, ENST00000553962, ENST00000553973, ENST00000554922, ENST00000555823, ENST00000971666
RefSeq mRNA: 3 — MANE Select: NM_183387
NM_001385116, NM_001411033, NM_183387
CCDS: CCDS45148, CCDS91916
Canonical transcript exons
ENST00000554922 — 44 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001379366 | 88688271 | 88688473 |
| ENSE00001632793 | 88649912 | 88649926 |
| ENSE00001634304 | 88714939 | 88715195 |
| ENSE00001657538 | 88712271 | 88712483 |
| ENSE00001664834 | 88740387 | 88740572 |
| ENSE00001666652 | 88726541 | 88726678 |
| ENSE00001695748 | 88744023 | 88744091 |
| ENSE00001716802 | 88746185 | 88746283 |
| ENSE00001728392 | 88646947 | 88646955 |
| ENSE00001731792 | 88738879 | 88739014 |
| ENSE00001747834 | 88754512 | 88754671 |
| ENSE00001780407 | 88706259 | 88706426 |
| ENSE00001788561 | 88736364 | 88736565 |
| ENSE00001805402 | 88792307 | 88792953 |
| ENSE00002529343 | 88612431 | 88615854 |
| ENSE00003458867 | 88658187 | 88658388 |
| ENSE00003477781 | 88624970 | 88625127 |
| ENSE00003491990 | 88657376 | 88657502 |
| ENSE00003500172 | 88618228 | 88618331 |
| ENSE00003512607 | 88661654 | 88661830 |
| ENSE00003518264 | 88687216 | 88687327 |
| ENSE00003525777 | 88627646 | 88627819 |
| ENSE00003548234 | 88638809 | 88638907 |
| ENSE00003552133 | 88681890 | 88682031 |
| ENSE00003554870 | 88704860 | 88704978 |
| ENSE00003564013 | 88694307 | 88694407 |
| ENSE00003570571 | 88705482 | 88705588 |
| ENSE00003575678 | 88620754 | 88620926 |
| ENSE00003576453 | 88663031 | 88663119 |
| ENSE00003585250 | 88685015 | 88685142 |
| ENSE00003609094 | 88626838 | 88627046 |
| ENSE00003614493 | 88695361 | 88695454 |
| ENSE00003627113 | 88696847 | 88696952 |
| ENSE00003627717 | 88616142 | 88616242 |
| ENSE00003628456 | 88621113 | 88621301 |
| ENSE00003633167 | 88618650 | 88618812 |
| ENSE00003651075 | 88642893 | 88643022 |
| ENSE00003655114 | 88702446 | 88702632 |
| ENSE00003657997 | 88634469 | 88634489 |
| ENSE00003666127 | 88644433 | 88644511 |
| ENSE00003666571 | 88664493 | 88664624 |
| ENSE00003672305 | 88622604 | 88622718 |
| ENSE00003681552 | 88665337 | 88665489 |
| ENSE00003684900 | 88616726 | 88616879 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 80.47.
FANTOM5 (CAGE): breadth broad, TPM avg 1.3038 / max 98.3933, expressed in 453 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144424 | 0.4370 | 201 |
| 144421 | 0.3701 | 179 |
| 144422 | 0.1942 | 93 |
| 144418 | 0.1398 | 51 |
| 144423 | 0.0905 | 38 |
| 144420 | 0.0441 | 15 |
| 144419 | 0.0281 | 9 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.47 | gold quality |
| left ovary | UBERON:0002119 | 79.51 | gold quality |
| secondary oocyte | CL:0000655 | 79.39 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.65 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 76.87 | gold quality |
| ovary | UBERON:0000992 | 76.67 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.33 | gold quality |
| cerebellum | UBERON:0002037 | 75.45 | gold quality |
| bone marrow cell | CL:0002092 | 75.24 | gold quality |
| right ovary | UBERON:0002118 | 74.56 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.59 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.65 | gold quality |
| cortical plate | UBERON:0005343 | 71.03 | gold quality |
| oviduct epithelium | UBERON:0004804 | 70.79 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.62 | gold quality |
| pancreas | UBERON:0001264 | 69.90 | gold quality |
| ventricular zone | UBERON:0003053 | 69.69 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.13 | gold quality |
| ganglionic eminence | UBERON:0004023 | 68.90 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 68.89 | gold quality |
| adrenal gland | UBERON:0002369 | 67.92 | gold quality |
| left adrenal gland | UBERON:0001234 | 67.85 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 67.18 | gold quality |
| body of pancreas | UBERON:0001150 | 66.54 | gold quality |
| mucosa of stomach | UBERON:0001199 | 66.44 | gold quality |
| prefrontal cortex | UBERON:0000451 | 65.99 | gold quality |
| adenohypophysis | UBERON:0002196 | 65.86 | gold quality |
| adrenal cortex | UBERON:0001235 | 65.64 | gold quality |
| oocyte | CL:0000023 | 65.40 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.75 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | eml5 | ENSDARG00000053517 |
| mus_musculus | Eml5 | ENSMUSG00000051166 |
| rattus_norvegicus | Eml5 | ENSRNOG00000004207 |
Paralogs (9): EML1 (ENSG00000066629), EML2 (ENSG00000125746), EML4 (ENSG00000143924), EML3 (ENSG00000149499), CFAP251 (ENSG00000158023), WDR90 (ENSG00000161996), CFAP52 (ENSG00000166596), CFAP44 (ENSG00000206530), EML6 (ENSG00000214595)
Protein
Protein identifiers
Echinoderm microtubule-associated protein-like 5 — Q05BV3 (reviewed: Q05BV3)
All UniProt accessions (4): Q05BV3, H0YJ79, H0YJS1, H0YJX1
UniProt curated annotations — full annotation on UniProt →
Function. May modify the assembly dynamics of microtubules, such that microtubules are slightly longer, but more dynamic.
Subcellular location. Cytoplasm. Cytoskeleton.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the WD repeat EMAP family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q05BV3-1 | 1 | yes |
| Q05BV3-2 | 2 | |
| Q05BV3-4 | 4 | |
| Q05BV3-5 | 5 |
RefSeq proteins (3): NP_001372045, NP_001397962, NP_899243* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR005108 | HELP | Conserved_site |
| IPR011041 | Quinoprot_gluc/sorb_DH_b-prop | Homologous_superfamily |
| IPR011047 | Quinoprotein_ADH-like_sf | Homologous_superfamily |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR019775 | WD40_repeat_CS | Conserved_site |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR050630 | WD_repeat_EMAP | Family |
| IPR055439 | Beta-prop_EML_1st | Domain |
| IPR055442 | Beta-prop_EML-like_2nd | Domain |
Pfam: PF03451, PF23409, PF23414
UniProt features (52 total): repeat 29, sequence conflict 10, splice variant 5, region of interest 3, compositionally biased region 3, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q05BV3-F1 | 87.18 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 139 (showing top):
TGGTGCT_MIR29A_MIR29B_MIR29C, GCANCTGNY_MYOD_Q6, MARTINEZ_RB1_TARGETS_UP, MARTINEZ_RB1_AND_TP53_TARGETS_UP, chr14q31, GOCC_CILIUM, GOMF_CYTOSKELETAL_PROTEIN_BINDING, CACTGCC_MIR34A_MIR34C_MIR449, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, EGR_Q6, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN, GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP, GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN
GO Biological Process (0):
GO Molecular Function (2): microtubule binding (GO:0008017), protein binding (GO:0005515)
GO Cellular Component (5): microtubule (GO:0005874), cilium (GO:0005929), extracellular exosome (GO:0070062), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| tubulin binding | 1 |
| binding | 1 |
| microtubule cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| extracellular vesicle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1517 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EML5 | ZNF500 | O60304 | 526 |
| EML5 | PTPN21 | Q16825 | 521 |
| EML5 | TTC8 | Q8TAM2 | 468 |
| EML5 | SPATA7 | Q9P0W8 | 449 |
| EML5 | TOP3B | O95985 | 447 |
| EML5 | ZC3H14 | Q6PJT7 | 446 |
| EML5 | CRTC3 | Q6UUV7 | 429 |
| EML5 | ELAVL2 | Q12926 | 409 |
| EML5 | SLC6A11 | P48066 | 398 |
| EML5 | RGS7 | P49802 | 398 |
| EML5 | PDE4D | Q08499 | 387 |
| EML5 | TTC7B | Q86TV6 | 380 |
| EML5 | CTSB | P07858 | 352 |
| EML5 | TYW1B | Q6NUM6 | 350 |
| EML5 | AGAP1 | Q9UPQ3 | 348 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DNAJC7 | PLD2 | psi-mi:“MI:0914”(association) | 0.640 |
| CRYBA4 | RBP4 | psi-mi:“MI:0914”(association) | 0.530 |
| EML5 | H3-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| EML5 | RPL27A | psi-mi:“MI:0915”(physical association) | 0.400 |
| EML5 | HNRNPD | psi-mi:“MI:0915”(physical association) | 0.400 |
| EML5 | STT3B | psi-mi:“MI:0915”(physical association) | 0.400 |
| PPP4R1L | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| DNAJA2 | DENND11 | psi-mi:“MI:0914”(association) | 0.350 |
| BTRC | ACOT7 | psi-mi:“MI:0914”(association) | 0.350 |
| TTC9C | PLD2 | psi-mi:“MI:0914”(association) | 0.350 |
| BTRC | BHLHE40 | psi-mi:“MI:0914”(association) | 0.350 |
| TTC8 | psi-mi:“MI:0914”(association) | 0.350 | |
| MST1R | SHTN1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CFAP161 | EML5 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (35): EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Proximity Label-MS), HNRNPD (Proximity Label-MS), STT3B (Proximity Label-MS), HIST3H3 (Proximity Label-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS), EML5 (Affinity Capture-MS)
ESM2 similar proteins: A2RRU3, A7MB12, A8XSW2, A8XYW9, G5ECZ4, G5EFW7, O13282, O14053, O43071, O75529, O94365, P25635, P38328, P40968, P42000, P49846, P87177, P91341, Q04199, Q04305, Q05946, Q05BV3, Q12220, Q15269, Q20059, Q3MKM6, Q5F3D7, Q5REE0, Q5RFQ3, Q5XGE2, Q6ED65, Q7ZW33, Q7ZXZ2, Q8BHB4, Q8BQM8, Q8BU03, Q8C7V3, Q8SQS4, Q8TED0, Q8VYZ5
Diamond homologs: O00423, O95834, Q05BC3, Q05BV3, Q26613, Q2TAF3, Q32P44, Q3UMY5, Q4V8C3, Q5SQM0, Q6DIP5, Q6ED65, Q6P6T4, Q6ZMW3, Q7TNG5, Q8BQM8, Q8VC03, Q9HC35, Q9N9X3, Q9VUI3, Q9Y1C1, A7RWD2, A8XL02, B0W517, B3N534, B4GT01, B4KKN1, B4LS78, B4MU54, O22466, O22467, O22468, O22469, O22607, O93377, P43254, P90916, P93471, Q09028, Q10G81
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
259 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 224 |
| Likely benign | 6 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
7097 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:88615707:C:CA | donor_gain | 1.0000 |
| 14:88615731:C:CT | donor_gain | 1.0000 |
| 14:88616724:A:AC | donor_gain | 1.0000 |
| 14:88616725:C:CC | donor_gain | 1.0000 |
| 14:88616725:CAA:C | donor_gain | 1.0000 |
| 14:88616725:CAAA:C | donor_gain | 1.0000 |
| 14:88616725:CAAAT:C | donor_gain | 1.0000 |
| 14:88616760:A:C | donor_gain | 1.0000 |
| 14:88616880:C:CC | acceptor_gain | 1.0000 |
| 14:88618341:C:CT | acceptor_gain | 1.0000 |
| 14:88618342:A:T | acceptor_gain | 1.0000 |
| 14:88618345:T:C | acceptor_gain | 1.0000 |
| 14:88618345:T:TC | acceptor_gain | 1.0000 |
| 14:88618644:CTGTA:C | donor_loss | 1.0000 |
| 14:88618645:TGTAC:T | donor_loss | 1.0000 |
| 14:88618648:A:T | donor_loss | 1.0000 |
| 14:88618649:C:CA | donor_loss | 1.0000 |
| 14:88618808:TAAAT:T | acceptor_gain | 1.0000 |
| 14:88618812:TCTG:T | acceptor_loss | 1.0000 |
| 14:88618813:C:CC | acceptor_gain | 1.0000 |
| 14:88618813:CTGA:C | acceptor_loss | 1.0000 |
| 14:88620212:T:C | donor_gain | 1.0000 |
| 14:88620924:CTT:C | acceptor_gain | 1.0000 |
| 14:88620925:TT:T | acceptor_gain | 1.0000 |
| 14:88620926:TC:T | acceptor_loss | 1.0000 |
| 14:88620927:C:CC | acceptor_gain | 1.0000 |
| 14:88620927:C:T | acceptor_loss | 1.0000 |
| 14:88620928:T:C | acceptor_loss | 1.0000 |
| 14:88620930:CATT:C | acceptor_gain | 1.0000 |
| 14:88620931:A:AC | acceptor_gain | 1.0000 |
AlphaMissense
13024 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:88616162:A:C | S1951R | 1.000 |
| 14:88616162:A:T | S1951R | 1.000 |
| 14:88616164:T:G | S1951R | 1.000 |
| 14:88622690:A:G | W1635R | 1.000 |
| 14:88622690:A:T | W1635R | 1.000 |
| 14:88625082:A:G | W1588R | 1.000 |
| 14:88625082:A:T | W1588R | 1.000 |
| 14:88625090:A:T | V1585D | 1.000 |
| 14:88664505:A:G | W1133R | 1.000 |
| 14:88664505:A:T | W1133R | 1.000 |
| 14:88681941:A:G | W1025R | 1.000 |
| 14:88681941:A:T | W1025R | 1.000 |
| 14:88687288:A:G | W928R | 1.000 |
| 14:88687288:A:T | W928R | 1.000 |
| 14:88696925:A:G | W756R | 1.000 |
| 14:88696925:A:T | W756R | 1.000 |
| 14:88706313:A:G | W591R | 1.000 |
| 14:88706313:A:T | W591R | 1.000 |
| 14:88726550:A:G | L393P | 1.000 |
| 14:88726674:A:G | W352R | 1.000 |
| 14:88726674:A:T | W352R | 1.000 |
| 14:88736367:A:T | V349D | 1.000 |
| 14:88736376:T:A | D346V | 1.000 |
| 14:88736377:C:G | D346H | 1.000 |
| 14:88736549:A:C | S288R | 1.000 |
| 14:88736549:A:T | S288R | 1.000 |
| 14:88736551:T:G | S288R | 1.000 |
| 14:88738942:A:G | W262R | 1.000 |
| 14:88738942:A:T | W262R | 1.000 |
| 14:88738956:C:T | G257D | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000016786 (14:88625207 G>A,T), RS1000046620 (14:88714241 C>A), RS1000050784 (14:88641128 C>A,G,T), RS1000052637 (14:88757822 T>C), RS1000089220 (14:88617697 G>C,T), RS1000092923 (14:88759634 T>C,G), RS1000099366 (14:88715182 C>G,T), RS1000106323 (14:88647499 C>A), RS1000113791 (14:88780725 G>A), RS1000165446 (14:88751481 A>G), RS1000165723 (14:88663776 C>T), RS1000189224 (14:88794895 G>C), RS1000196214 (14:88778110 G>T), RS1000201425 (14:88711309 T>A,C), RS1000213692 (14:88755865 A>C)
Disease associations
OMIM: gene MIM:618119 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation, decreases expression, affects cotreatment | 2 |
| sodium arsenite | increases expression | 2 |
| methylmercuric chloride | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| coumarin | decreases phosphorylation | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| tanespimycin | affects cotreatment, increases expression | 1 |
| 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide | increases expression | 1 |
| STA 9090 | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| VER 155008 | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Thimerosal | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Vanadates | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.